Acerus To Report Q1-2022 Financial Results And Host Investor Call
05 Mai 2022 - 1:30PM
Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCD) will
announce its first quarter 2022 financial and operating results on
Tuesday, May 10, 2022 before the market opens. The company will
also host a conference call on Tuesday, May 10, 2022 at 10:00 a.m.
Eastern Time.
To access the call live, please dial
416-406-0743 or 1-800-898-3989 and use access code 3384602#.
Listeners are encouraged to dial in 10 minutes before the call
begins to avoid delays. A replay of the conference call will be
available until 11:59 p.m. Eastern Time on Tuesday, May 17, 2022 by
dialing 905-694-9451 or 1-800-408-3053, using access code:
1602409#.
About Acerus
Acerus Pharmaceuticals Corporation is a
Canadian-based specialty pharmaceutical company focused on the
commercialization and development of innovative prescription
products that improve patient experience, with a primary focus in
the field of men’s health. The Company commercializes its products
via its own salesforce in the United States and Canada, and through
a global network of licensed distributors in other territories.
Acerus’ shares trade on TSX under the symbol ASP
and on OTCQB under the symbol ASPCD. For more information,
visit www.aceruspharma.com and follow us
on Twitter and LinkedIn.
Company Contactir@aceruspharma.com
Investor Relations ContactChris WittyAcerus
Investor Relations (646) 438-9385cwitty@darrowir.com
Acerus Pharmaceuticals (TSX:ASP)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
Acerus Pharmaceuticals (TSX:ASP)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024
Real-Time news about Acerus Pharmaceuticals Corporation (Toronto Stock Exchange): 0 recent articles
Plus d'articles sur